Start Time: 16:30 January 1, 0000 5:29 PM ET
Veracyte, Inc. (NASDAQ:VCYT)
Q4 2022 Earnings Conference Call
February 22, 2023, 16:30 PM ET
Company Participants
Marc Stapley - CEO
Rebecca Chambers - EVP and CFO
Tina Nova - President, U.S. CLIA Business
Shayla Gorman - Director, IR
Conference Call Participants
Andrew Brackman - William Blair
Dave Delahunt - Goldman Sachs
Puneet Souda - SVB Securities
Mason Carrico - Stephens, Inc
Mike Matson - Needham & Company
Yuko Oku - Morgan Stanley
Andrew Cooper - Raymond James
Sung Ji Nam - Scotiabank
Operator
Good day and thank you for standing by. Welcome to the Veracyte Fourth Quarter and Full Year 2022 Financial Results Webcast. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]. Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Ms. Shayla Gorman. Ms. Gorman, please begin.
Shayla Gorman
Good afternoon, everyone, and thanks for joining us today for a discussion of our fourth quarter and full year 2022 financial results. With me today are Marc Stapley, Veracyte's Chief Executive Officer; Rebecca Chambers, our Chief Financial Officer; and Dr. Tina Nova.
Veracyte issued a press release earlier this afternoon detailing our fourth quarter and full year 2022 financial results. This release, along with a business and financial presentation, is available in the Investor Relations section of our Web site at veracyte.com.
Before we begin, I'd like to remind you that various statements that we may make during this call will include forward-looking statements as defined under applicable securities laws. Forward-looking statements are subject to risks and uncertainties and the company can give no assurance they will prove to be correct. Further, we are not under any obligation to provide further updates on our business trends or our performance during the quarter. To better understand the risks and uncertainties that could cause actual results to differ, we refer you to the documents that Veracyte files with the Securities and Exchange Commission, including Veracyte's most recent Forms 10-Q and 10-K.
In addition, this call will include certain non-GAAP financial measures. Reconciliation of these measures to the most directly comparable GAAP financial measures are included in today's earnings release, accessible from the IR section of Veracyte's Web site.
I will now turn the call over to Marc Stapley, Veracyte's CEO.